Private importing
Shopping Guide
    Request Form     Request Form for Corporate Service

Product Overview/Feature

  • Tsumura Bouhuutsuusyousan [62] : 189 bags
  • JP

Code:005390-001

Tsumura Bouhuutsuusyousan [62] : 189 bags

Sale Price:US$101.49

Warehouse Japan1
Manufacturer TSUMURA & CO.
Brand TSUMURA & CO.
JAN Code 4987138806239
GS1 14987138806236
Ingredient Code 5200130
Shipping Schedule 5 to 10 days

Description

Bofutsushosan is indicated forthe relief of the followingsymptoms of those patients with thick subcutaneous fat in the abdomen and a tendency to constipation:Accessory symptoms associated with hypertension (palpitation,shoulder stiffness, and hot flushes),obesity, swelling, and constipation.

Presentation

189 bags

Feature

Extract Granules

Active Ingredients

7.5g(3bags for 1day): TSUMURA Bofutsushosan extract granules contains 4.5 g of a dried extract of the following mixed crude drugs.JP Alminum Silicate Hydrate withSilicon Dioxide 3.0 gJP Scutellaria Root 2.0 gJP Glycyrrhiza 2.0 gJP Platycodon Root 2.0 gJP Gypsum 2.0 gJP Atractylodes Rhizome 2.0 gJP Rhubarb 1.5 gJP Schizonepeta Spike 1.2 gJP Gardenia Fruit 1.2 gJP Peony Root 1.2 gJP Cnidium Rhizome 1.2 gJP Japanese Angelica Root 1.2 gJP Mentha Herb 1.2 gJP Saposhnikovia Root 1.2 gJP Ephedra Herb 1.2 gJP Forsythia Fruit 1.2 gJP Ginger 0.3 ganhydrous Mirabilitum 0.7 g(JP: The Japanese Pharmacopoeia)

Effect/Efficacy

TJ-62 is indicated for the relief of the following symptoms of those patients with thick subcutaneous fat in the abdomen and a tendency to constipation:

Accessory symptoms associated with hypertension (palpitation, shoulder stiffness, and hot flushes), obesity, swelling, and constipation.

Usage/Dosage

The usual adult dose is 7.5 g/day orally in 2 or 3 divided doses before or between meals. The dosage may be adjusted according to the patient's age and body weight, and symptom

Cautions

1.Careful administration(TJ-62should be administered with care in the following patients.)
(1)Patients with diarrhea or soft feces [These symptoms may be aggravated.]
(2)Patients with weak gastrointestinal tract[Anorexia, epigastric distress, nausea, vomiting, abdominal pain, soft feces, diarrhea, etc. may occur.]
(3)Patients with anorexia, nausea or vomiting [These symptoms may be aggravated.]
(4)Patients in a period of weakness after disease or with greatly declined constitution [Adverse reactions are likely to occur, and the symptoms may be aggravated.]
(5)Patients showing a remarkable tendency of sweating [Excess sweating and/or generalized weakness may occur.]
(6)Patients with cardiovascular disorders including angina pectoris and myocardial infarction, etc. or those with a history of such disorders.
(7)Patients with severe hypertension
(8)Patients with severe renal dysfunction
(9)Patients with dysuria
(10)Patients with hyperthyroidism[(6)-(10): These disease and symptoms may be aggravated.]

2.Important Precautions
(1)When TJ-62 is used, the patient’s“SHO” (constitution/symptoms) should be taken into account. The patient’s progress should be carefully monitored, and if no improvement in symptoms/findings is observed, continuous treatment should be avoided.
(2)Since TJ-62contains Glycyrrhiza, careful attention should be paid to the serum potassium level, blood pressure, etc., and if any abnormality is observed, adminis-tration should be discontinued.
(3)When TJ-62is coadministered with other Kampo-preparations (Japanese traditional herbal medicines),etc., attention should be paid to the duplication of the contained crude drugs. Special caution should be exercised when TJ-62is coadministered with preparations containing Rhubarb.
.
(4) Since there is an individual difference in the cathartic action of Rhubarb, caution should be exercised concerning the dosage and administration.

SHO:
The term “SHO”refers to a particular pathological status of a patient evaluated by the Kampo diagnosis, and is patterned according to the patient’s constitution, symptoms, etc.
Kampo-preparations (Japanese traditional herbal medicines) should be used after confirmation that it is suitable for the いidentified “SHO” of the patient.

Contraindication